Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Rheostat Therapeutics Raises $23 Million from Heavyweight Pharma Companies in Series A Round
Rheostat Therapeutics Raises $23 Million from Heavyweight Pharma Companies in Series A Round
Rheostat Therapeutics Raises $23 Million from Heavyweight Pharma Companies in Series A Round
Submitted by
admin
on November 26, 2018 - 10:21am
Source:
CP Wire
News Tags:
Rheostat Therapeutics
Merck
AbbVie
Amgen
Headline:
Rheostat Therapeutics Raises $23 Million from Heavyweight Pharma Companies in Series A Round
snippet:
Merck, Abbvie and Amgen VC groups participated
Rheostat is focused on developing novel treatments for neurodegeneration, cognition and rare diseases
Do Not Allow Advertisers to Use My Personal information
